Fosaprepitant Impurity 4, with the CAS number 1523569-85-8, is a chemical compound that is recognized as an impurity associated with the synthesis of fosaprepitant, a medication used primarily as an antiemetic to prevent nausea and vomiting caused by chemotherapy. While specific characteristics such as molecular weight, structure, and solubility may vary, impurities like this one are typically characterized by their stability, reactivity, and potential effects on the efficacy and safety of the primary drug. Impurities can arise during the manufacturing process and may influence the pharmacological profile of the final product. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the properties and behavior of impurities is crucial for ensuring the quality and safety of pharmaceutical products, as they can impact both therapeutic outcomes and regulatory compliance.

Fosaprepitant Impurity 4

1523569-85-8: Fosaprepitant Impurity 4, with the CAS number 1523569-85-8, is a chemical compound that is recognized as an impurity associated with the synthesis of fosaprepitant, a medication used primarily as an antiemetic to prevent nausea and vomiting caused by chemotherapy. While specific characteristics such as molecular weight, structure, and solubility may vary, impurities like this one are typically characterized by their stability, reactivity, and potential effects on the efficacy and safety of the primary drug. Impurities can arise during the manufacturing process and may influence the pharmacological profile of the final product. Analytical techniques such as high-performance liquid chromatography (HPLC) and mass spectrometry are often employed to identify and quantify such impurities in pharmaceutical formulations. Understanding the properties and behavior of impurities is crucial for ensuring the quality and safety of pharmaceutical products, as they can impact both therapeutic outcomes and regulatory compliance.

CAS 1523569-85-8

Fosaprepitant Impurity 4

Fosaprepitant Impurity 20

Ref: 4Z-F-3628